EcoDrugPlus

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSACLG00000016144
Gene Symbol: LOC113031633
2 Cross references
191 Possible Orthologues:

Granzyme B(G,h)-Like

Ensembl ID : ENSACLG00000004365
Gene Symbol: LOC113016981
2 Cross references
1069 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSACLG00000020830
Gene Symbol: LOC113016733
2 Cross references
1021 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSACLG00000004346
Gene Symbol: LOC113016785
2 Cross references
1021 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSACLG00000024510
Gene Symbol: GHRHR
2 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSACLG00000006359
Gene Symbol: GHSR
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSACLG00000020054
Gene Symbol: GUCY1A1
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSACLG00000022829
Gene Symbol: GUCY1A2
4 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSACLG00000019984
Gene Symbol: GUCY1B1
3 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSACLG00000024203
Gene Symbol: HSP90AB1
3 Cross references
355 Possible Orthologues:

High Mobility Group Box 1b

Ensembl ID : ENSACLG00000000621
Gene Symbol: HMGB1B
1 Cross references
512 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSACLG00000004323
Gene Symbol: LOC113030724
2 Cross references
498 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).